D.E. Shaw & Co
CYTK icon

D.E. Shaw & Co’s Cytokinetics CYTK Stock Holding History

D.E. Shaw & Co’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.68M Sell
40,700
-40,800
-50% -$2.59M ﹤0.01% 2692
2025
Q4 		$5.18M Buy
81,500
+8,800
+12% +$547K ﹤0.01% 2268
2025
Q3 		$4M Sell
72,700
-8,900
-11% -$367K ﹤0.01% 2416
2025
Q2 		$2.7M Buy
81,600
+8,900
+12% +$310K ﹤0.01% 2516
2025
Q1 		$2.92M Sell
72,700
-11,600
-14% -$533K ﹤0.01% 2322
2024
Q4 		$3.97M Sell
84,300
-35,000
-29% -$1.82M ﹤0.01% 2165
2024
Q3 		$6.3M Hold
119,300
– – 0.01% 1775
2024
Q2 		$6.46M Buy
119,300
+55,000
+86% +$3.32M 0.01% 1654
2024
Q1 		$4.51M Buy
+64,300
New +$4.97M ﹤0.01% 1972

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return